Found: 103
Select item for more details and to access through your institution.
The Role of Integrins in Colorectal Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 21
- By:
- Publication type:
- Article
Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro.
- Published in:
- Prostate, 2000, v. 43, n. 3, p. 161, doi. 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O
- By:
- Publication type:
- Article
Molecular basis for sunitinib efficacy and future clinical development.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Current development of mTOR inhibitors as anticancer agents.
- Published in:
- 2006
- By:
- Publication type:
- research
Clinical Activity of Lenalidomide in Visceral Human Immunodeficiency Virus-Related Kaposi Sarcoma.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 11, p. 1319, doi. 10.1001/jamadermatol.2013.5751
- By:
- Publication type:
- Article
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1440-4
- By:
- Publication type:
- Article
To the editor.
- Published in:
- 2011
- By:
- Publication type:
- Letter
From Van Gogh to Lady Gaga: Artist eccentricity increases perceived artistic skill and art appreciation.
- Published in:
- European Journal of Social Psychology, 2014, v. 44, n. 2, p. 93, doi. 10.1002/ejsp.1999
- By:
- Publication type:
- Article
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
How Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant Association.
- Published in:
- Schizophrenia Bulletin, 2011, v. 37, n. 4, p. 811, doi. 10.1093/schbul/sbp148
- By:
- Publication type:
- Article
Novel molecular therapies in hepatocellular carcinoma.
- Published in:
- Liver International, 2011, v. 31, p. 151, doi. 10.1111/j.1478-3231.2010.02395.x
- By:
- Publication type:
- Article
Stromal expression of SPARC in pancreatic adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 3/4, p. 585, doi. 10.1007/s10555-013-9439-3
- By:
- Publication type:
- Article
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2013, v. 32, n. 1/2, p. 147, doi. 10.1007/s10555-012-9396-2
- By:
- Publication type:
- Article
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.
- Published in:
- Cancer & Metastasis Reviews, 2011, v. 30, p. 19, doi. 10.1007/s10555-011-9291-2
- By:
- Publication type:
- Article
Future perspectives on neuroendocrine tumors.
- Published in:
- Cancer & Metastasis Reviews, 2011, v. 30, p. 35, doi. 10.1007/s10555-011-9294-z
- By:
- Publication type:
- Article
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
- Published in:
- Neuroendocrinology, 2018, v. 107, n. 3, p. 237, doi. 10.1159/000491999
- By:
- Publication type:
- Article
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
- Published in:
- Neuroendocrinology, 2018, v. 107, n. 1, p. 24, doi. 10.1159/000487237
- By:
- Publication type:
- Article
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241289200
- By:
- Publication type:
- Article
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156382
- By:
- Publication type:
- Article
Management of unexpected laboratory exposure to Burkholderia pseudomallei.
- Published in:
- Annales de Biologie Clinique, 2023, v. 81, n. 6, p. 640, doi. 10.1684/abc.2023.1854
- By:
- Publication type:
- Article
The Role of Cultural Heterogeneity in Strengthening the Link Between Family Relationships and Life Satisfaction in 50 Societies.
- Published in:
- Journal of Happiness Studies, 2024, v. 25, n. 6, p. 1, doi. 10.1007/s10902-024-00768-1
- By:
- Publication type:
- Article
Introduction to a Culturally Sensitive Measure of Well-Being: Combining Life Satisfaction and Interdependent Happiness Across 49 Different Cultures.
- Published in:
- Journal of Happiness Studies, 2023, v. 24, n. 2, p. 607, doi. 10.1007/s10902-022-00588-1
- By:
- Publication type:
- Article
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1135, doi. 10.1007/s10637-019-00741-3
- By:
- Publication type:
- Article
Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1206, doi. 10.1007/s10637-015-0286-7
- By:
- Publication type:
- Article
The Cathedral and the Bazaar.
- Published in:
- Knowledge, Technology & Policy, 1999, v. 12, n. 3, p. 23, doi. 10.1007/s12130-999-1026-0
- By:
- Publication type:
- Article
Interview: LifeBiotic Founder, Yair Maimon, DOM, PhD, AC.
- Published in:
- JASA: Journal of the American Society of Acupuncturists, 2020, v. 7, n. 4, p. 41
- By:
- Publication type:
- Article
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13040
- By:
- Publication type:
- Article
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184509
- By:
- Publication type:
- Article
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterasesensitive cross-linker in patients with advanced malignancies: a Phase I study.
- Published in:
- International Journal of Nanomedicine, 2016, v. 11, p. 6207, doi. 10.2147/IJN.S110274
- By:
- Publication type:
- Article
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma.
- Published in:
- Cancer (0008543X), 1997, v. 79, n. 6, p. 1100, doi. 10.1002/(SICI)1097-0142(19970315)79:6<1100::AID-CNCR7>3.0.CO;2-J
- By:
- Publication type:
- Article
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
- Published in:
- 1997
- By:
- Publication type:
- journal article
Logistic regression model of fotemustine toxicity combining independent phase II studies.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 9, p. 1980, doi. 10.1002/(SICI)1097-0142(19961101)78:9<1980::AID-CNCR20>3.0.CO;2-T
- By:
- Publication type:
- Article
Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound.
- Published in:
- Marine Drugs, 2013, v. 11, n. 3, p. 944, doi. 10.3390/md11030944
- By:
- Publication type:
- Article
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11065-0
- By:
- Publication type:
- Article
A TALE OF TWO CITIES: AN EXPLORATORY STUDY OF CONSOLIDATION AND ANNEXATION POLICIES IN THE CITIES OF MEMPHIS AND NASHVILLE.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1468, doi. 10.1111/liv.14113
- By:
- Publication type:
- Article
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 500, doi. 10.1007/s10637-013-0060-7
- By:
- Publication type:
- Article
Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1142, doi. 10.1007/s10637-013-9932-0
- By:
- Publication type:
- Article
Antiangiogenic treatments and mechanisms of action in renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1791, doi. 10.1007/s10637-011-9677-6
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of etaracizumab (Abegrinâ¢), a humanized monoclonal antibody against α<sub>v</sub>β<sub>3</sub> integrin receptor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 1, p. 35, doi. 10.1007/s10637-007-9077-0
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2Â weeks in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 5, p. 453, doi. 10.1007/s10637-007-9071-6
- By:
- Publication type:
- Article
Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx<sup>®</sup>) in combination with topotecan in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 5, p. 413
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 311, doi. 10.1007/s10637-005-5055-6
- By:
- Publication type:
- Article
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 3, p. 225, doi. 10.1007/s10637-005-6730-3
- By:
- Publication type:
- Article
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy.
- Published in:
- Drugs, 2000, v. 60, p. 15, doi. 10.2165/00003495-200060001-00002
- By:
- Publication type:
- Article